secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2023-11-28T23:59:59+00:00
Accession:  0001753926-23-001555
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella receives Nasdaq deficiency notice for potential minimum equity violation
--------------------------------------------------------------------------------

- Received Nasdaq notice on Nov 21, 2023, for failure to maintain minimum $2.5M stockholders' equity as of Sep 30, 2023.
- No immediate effect on listing of LIPO common stock; continues to trade normally.
- Company evaluating measures to regain compliance but cannot assure success.
- If not remedied, Nasdaq may delist the stock; compliance deadline not specified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623001555/0001753926-23-001555-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623001555/g083873_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-23-001555

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer